Dicerna Pharmaceuticals
DRNA
#4014
Rank
A$4.49 B
Marketcap
A$57.64
Share price
0.00%
Change (1 day)
16,902.57%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: A$4.49 Billion

As of November 2026 Dicerna Pharmaceuticals has a market cap of A$4.49 Billion. This makes Dicerna Pharmaceuticals the world's 4014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022A$4.37 B6.54%
2021A$4.10 B89.24%
2020A$2.17 B-3.62%
2019A$2.25 B117.58%
2018A$1.03 B73.29%
2017A$0.59 B620.38%
2016A$82.91 M-75.29%
2015A$0.33 B-6.25%
2014A$0.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$235.51 B 5,144.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$355.34 B 7,813.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$497.11 B 10,970.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.85 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.04 B 546.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$8.81 B 96.41%๐Ÿ‡บ๐Ÿ‡ธ USA